Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Rambau

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The American Journal of Surgical Pathology|January 27, 2017
Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the OvaryPeter F Rambau, John B McIntyre, Jennifer Taylor, et al.
Gynecologic Oncology|April 14, 2016
Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) studyMartin Köbel, Eshetu G Atenafu, Peter F Rambau, et al.
The Journal of Pathology. Clinical Research|May 12, 2020
Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinomaAngela My Chan, Emeka Enwere, John B McIntyre, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2016
An Immunohistochemical Algorithm for Ovarian Carcinoma TypingMartin Köbel, Kurosh Rahimi, Peter F Rambau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian CancerDale W Garsed, Kathryn Alsop, Sian Fereday, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Mayo Clinic Proceedings|March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S Block, Robert A Vierkant, Peter F Rambau, et al.
The Journal of Pathology. Clinical Research|August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium studyPeter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
JAMA Oncology|October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer, Ellen L Goode, Matthew S Block, et al.
The Journal of Pathology. Clinical Research|March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Eun-Young Kang, Ashley Weir, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The American Journal of Surgical Pathology|January 27, 2017
Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the OvaryPeter F Rambau, John B McIntyre, Jennifer Taylor, et al.
Gynecologic Oncology|April 14, 2016
Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) studyMartin Köbel, Eshetu G Atenafu, Peter F Rambau, et al.
The Journal of Pathology. Clinical Research|May 12, 2020
Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinomaAngela My Chan, Emeka Enwere, John B McIntyre, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 15, 2016
An Immunohistochemical Algorithm for Ovarian Carcinoma TypingMartin Köbel, Kurosh Rahimi, Peter F Rambau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian CancerDale W Garsed, Kathryn Alsop, Sian Fereday, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Mayo Clinic Proceedings|March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian CancerMatthew S Block, Robert A Vierkant, Peter F Rambau, et al.
The Journal of Pathology. Clinical Research|August 1, 2018
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium studyPeter F Rambau, Robert A Vierkant, Maria P Intermaggio, et al.
JAMA Oncology|October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer, Ellen L Goode, Matthew S Block, et al.
The Journal of Pathology. Clinical Research|March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Eun-Young Kang, Ashley Weir, et al.
Pageof 4